Impact case studies
Our NIHR Southampton Clinical Research Facility (NIHR CRF) plays a key role in driving new treatments and practice to the clinic, delivering research and commercial trials driving new therapies and rapidly advancing patient health.
Here you can discover more about the pioneering research taking place at the facility and learn more about the wide reaching impact of our work.
Lynchpin in $220M fight against breathlessness
Our unit involved in the emergence of a $220M drug development programme aiming to minimise the impact of the common cold and other viruses on asthma and COPD sufferers. Read more
Enabling new antimicrobial therapies
Chronic lung infection in cystic fibrosis is a serious issue; our novel assays of bacterial biofilm degredation are one aspect of our central role in biotech firm Antabio's €3.9million Wellcome Trust Seeding Drug Discovery award.Read more
Landmark study could save NHS £100 million
The facility was central to a UK-wide trial demonstrating that wet age-related macular degeneration (AMD) can be treated with a drug 10 times cheaper than the current treatment, representing a potential saving of £100 million per year. Read more